Scynexis completes transfer of Brexafemme New Drug Application To GSK

Reuters
2025.11.19 12:11
Nov 19 (Reuters) - SCYNEXIS Inc (SCYX.O) : * SCYNEXIS COMPLETES TRANSFER OF BREXAFEMME® NEW DRUG APPLICATION TO GSK * SCYNEXIS INC - TO RECEIVE UP TO $145.5 MILLION IN ANNUAL NET SALES MILESTONES AS WELL AS ROYALTIES Source text: Further company coverage: (SCYX.O)
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer